Capital Advisory Group Advisory Services, LLC Beam Therapeutics Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

$210 Million
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$68.02 - $99.06 $2,720 - $3,962	-40 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $3,374 - $5,344	40 New	40 $3,000

Others Institutions Holding BEAM

# of Institutions

243

Shares Held

65.6M

Call Options Held

311K

Put Options Held

777K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.18M
Shares

$195 Million
1.93% of portfolio
Vanguard Group Inc Valley Forge, PA

7.58M
Shares

$181 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.71M
Shares

$160 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

4.51M
Shares

$108 Million
0.7% of portfolio
Morgan Stanley New York, NY

4.12M
Shares

$98.3 Million
0.01% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.68B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account